Eradivir $10M Trigger: Dial Your Next Deal
Eradivir lands $10M. Get CEO contact, pain points, pitch angles. Next touch ready. Close faster.
Published on
Do not index
Do not index
🚀 Battle Card: Eradivir
Quick trigger:
👤 Decision Maker in the News
- Martin Low, CEO 📧 <martin.low@eradivir.com>
💡 Why It Matters
- A $10M financing supercharges Phase 2 challenge trials of EV25 and advances EV148 RSV development → Source
🎯 Core Pain Point
- Meeting aggressive Phase 2 trial milestones
- Securing follow-on funding for pipeline expansion
💰 What to Pitch
- Primary: eClinical trial management software → Accelerate trial workflows and data accuracy
- Expansion: AI-driven patient recruitment tool → Reduce enrollment time
🗺️ Quick Context
- HQ: West Lafayette, IN
- Employees: ≈ 50
- Rev: ≈ $2 M
🤼 Competitive Intel
Which other vendors you’ll probably face to win Eradivir’s business.
- Medidata — eClinical / CTMS
- Unique edge: Global trial data integration
- Evaluated by VP Ops for workflow centralization
- Veeva — eClinical / CTMS
- Unique edge: Unified clinical cloud
- Evaluated by IT & CTO for system interoperability
- Oracle Health Sciences — eClinical / CTMS
- Unique edge: Robust analytics and scalability
- Evaluated by CFO for total cost of ownership
- Medrio — eClinical / CTMS
- Unique edge: Lightweight, modular design
- Evaluated by Clinical Ops for rapid deployment
✅ Do-Now Checklist
Tailor first touch to this Eradivir sales trigger (Raises $10M)
Connect with Martin Low on LinkedIn (link above)
Generate email + DM with the Copy-My-Prompt block (Step 7) and send first touch
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
Get intel like this daily—no fluff, all pipeline. Never miss an Eradivir sales trigger.
Subscribe to NewsletterForLeads for your next Eradivir sales trigger.
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑≈ TBD❑
OFFER_BRIEF = ❑eClinical trial management software❑
PROOF_METRIC = ❑≈ TBD❑
CTA_STYLE = ❑quick_call❑
TONE = ❑friendly❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Martin
COMPANY = Eradivir
DEPT = Clinical Operations
SIZE = ≈ 50
BOTTLENECK = Meeting aggressive Phase 2 trial milestones
EVENT = Raises $10M
DETAIL = closing of a $10M private financing round
PAIN = Meeting aggressive Phase 2 trial milestones
SRC = https://vcnewsdaily.com/eradivir/venture-capital-funding/tbctplhxzc
SIM_CO = ≈ TBD
WIN_METRIC = ≈ TBD
NEXT_SIZE = ≈ TBD
EMP_EST = ≈ 50
REV_EST = ≈ $2 M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: ≈ 50-person Clinical Operations
Martin—noticed your Clinical Operations team is ≈ 50.
That’s when Meeting aggressive Phase 2 trial milestones slows growth.
We helped ≈ TBD fix this with eClinical trial management software.
Result: ≈ TBD.
Quick call?
PS—next bottleneck hits ≈ TBD.
DM ≤45 words, TONE:
Saw your post about closing of a $10M private financing round — Meeting aggressive Phase 2 trial milestones.
eClinical trial management software. ≈ TBD.
Quick chat?